This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Array BioPharma Inc
ARRY : NASDAQ : Health Care
$4.07 -0.03 | -0.73%
Today's Range: 3.97 - 4.14
Avg. Daily Volume: 1,771,300
07/10/14 - 3:51 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
ARRY ARRAY BIOPHARMA INC 4.44 559.37 n/m 61.48 -5.17
ARWR ARROWHEAD RESEARCH CORP 13.89 720.50 n/m 0.18 -40.68
EXEL EXELIXIS INC 3.64 708.69 n/m 26.57 -31.18
NLNK NEWLINK GENETICS CORP 25.40 708.00 n/m 1.13 -25.89
ANAC ANACOR PHARMACEUTICALS INC 16.82 704.96 9.72 19.68 96.17
MNTA MOMENTA PHARMACEUTICALS INC 12.50 659.31 n/m 38.65 -18.29
INO INOVIO PHARMACEUTICALS INC 9.16 551.05 n/m 14.37 270.26
SPPI SPECTRUM PHARMACEUTICALS INC 8.29 543.67 n/m 155.93 -35.11
OSIR OSIRIS THERAPEUTICS INC 15.74 538.65 787.00 30.12 153.03
HPTX HYPERION THERAPEUTICS INC 25.52 525.13 20.25 60.90 7678.28
PRTA PROTHENA CORP PLC 23.91 523.75 n/m 32.74 4288.60
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

ARRY Ind Avg S&P 500
n/m 57.62 19.55
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners


Top Rated Stocks Top Rated Funds Top Rated ETFs